medigraphic.com
ISSN 2594-3006 (Electronic)
ISSN 2007-1752 (Print)
Archivos de Medicina de Urgencia de México

2025, Number 2-3

<< Back Next >>

Arch Med Urg Mex 2025; 17 (2-3)

Hospital stay in patients with Systemic Lupus Erythematosus

Vázquez-Rodríguez JG, García-Bello JA, Vázquez-Arredondo JG

Language: Spanish
References: 28
Page: 105- 117
PDF size: 313.06 Kb.


ABSTRACT

This narrative review addresses the clinical topic of patients with Systemic Lupus Erythematosus (SLE) and the most relevant but necessary aspects for the medical community, such as their medical history, key epidemiological data, clinical picture, diagnosis, SLE classification, and estimated lupus activity from the first contact, the most common causes of hospital admission, length of stay, rates of admission to the Intensive Care Unit, mortality, and associated factors reported in international and Mexican research.
The in-depth reviews of experts and international groups were abandoned in favor of a simple, understandable, and concise narrative of each of the subtopics, supported by the most representative references illustrated with tables and figures.
General practitioners, family physicians, emergency medicine specialists, and various subspecialists frequently have to care for patients with SLE because it is the autoimmune disease with the highest incidence and prevalence in the world and in our country. The intention of this narrative review is for readers, whether experts or not, to quickly grasp at first glance the most important message of each topic, using a practical approach to facilitate the care of their patients with SLE and accurately answer the most common questions.


REFERENCES

  1. Felten R, Lipsker D, Sibilia J, Chasset F, Arnaud L. The history oflupus throughout the ages. J Am Acad Dermatol. 2022;87(6):1361-1369. DOI: 10.1016/j.jaad.2020.04.150.

  2. Narváez J. Lupus eritematoso sistémico 2020. Med Clin (Barc).2020;155(11):494-501. DOI: 10.1016/j.medcli.2020.05.009

  3. Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiologyof systemic lupus erythematosus: a comprehensive systematicanalysis and modelling study. Ann Rheum Dis. 2023;82(3):351-356. DOI: 10.1136/ard-2022-223035.

  4. Mendoza-Pinto C, Etchegaray-Morales I, Munguía-Realpozo P,Solís-Poblano JC, Méndez-Martínez S, Osorio-Peña AD, et al.Trends in all-cause hospitalizations for systemic lupus erythematosusin Mexico, 2000–2019. Lupus. 2022;31(13):1679–1684.DOI: 10.1177/09612033221128745

  5. Bertsias GK, Pamfil C, Fanouriakis A, Boumpas DT. Diagnostic criteriafor systemic lupus erythematosus: has the time come? Nat RevRheumatol. 2013;9(11):687-694. DOI: 10.1038/nrrheum.2013.103.

  6. Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update οnthe diagnosis and management of systemic lupus erythematosus.Ann Rheum Dis. 2021;80:14-25. DOI: 10.1136/annrheumdis-2020-218272

  7. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M,Ramsey-Golman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteriafor systemic lupus erythematosus. Arthritis Rheumatol.2019;71(9):1400–1412. DOI: 10.1002/art.40930.

  8. Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE,Appel GB, et al. International Society of Nephrology Working Groupon the Classification of Lupus Nephritis; Renal Pathology SocietyWorking Group on the Classification of Lupus Nephritis. The classificationof glomerulonephritis in systemic lupus erythematosusrevisited. Kidney Int. 2004;65(2):521-530. DOI: 10.1111/j.1523-1755.2004.00443.x Fé de erratas en: Kidney Int. 2004;65(3):1132.PMID: 14717922. Disponible en: https://www.kidney-international.org/action/showPdf?pii=S0085-2538%2815%2949734-0

  9. Aringer M, Johnson SR. Classifying and diagnosing systemic lupuserythematosus in the 21st century. Rheumatology. 2020;59:v4–v11. DOI: 10.1093/rheumatology/keaa379

  10. Bencivelli VC, Isenberg DA, Smolen JS, Snaith ML, Sciuto M,Neri R, et al. Disease activity in systemic lupus erythematosus:report of the Consensus Study Group of the European Workshopfor Rheumatology Research. III. Development of a computerizedclinical chart and its application to the comparison of different indicesof disease activity. The European Consensus Study Groupfor Disease Activity in SLE. Clin Exp Rheumatol. 1992;10(5):549-554. PMID: 1458711. Disponible en: https://europepmc.org/article/med/1458710

  11. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosusdisease activity index 2000. J Rheumatol. 2002;29(2):288-291. PMID: 11838846. Disponible en: https://www.jrheum.org/content/jrheum/29/2/288.full.pdf

  12. Calculators (2024). Disponible en: https://www.cuba.dialogoroche.com/es/home/assets-for-you/tools-and-assets/calculators/rheumatology/sledai.html

  13. Edwards CJ, Lian TY, Badsha H, Teh CL, Arden N, Chng HH.Hospitalization of individuals with systemic lupus erythematosus:characteristics and predictors of outcome. Lupus. 2003;12(9):672-676. DOI: 10.1191/0961203303lu452oa

  14. Teh CL, Chan GYL, Lee J. Systemic lupus erythematosus in atertiary, east Malaysian hospital: admission, readmission anddeath. Int J Rheum Dis. 2008;11(1):24-29. DOI: 10.1111/j.1756-185X.2008.00325.x

  15. Pacheco D, Alvarez ME, Vizcarra G, Fuentealba C, Marinovic MA,Ballesteros F. Características de la hospitalización reumatológicaen un hospital de nivel terciario. Rev Med Chil. 2001;129(6):653-659. DOI: 10.4067/S0034-98872001000600009

  16. Lee J, Dhillon N, Pope J. All-cause hospitalizations in systemiclupus erythematosus from a large Canadian referral centre. Rheumatology(Oxford). 2013;52(5):905-909. DOI: 10.1093/rheumatology/kes391

  17. Busch RW, Kay SD, Voss A. Hospitalizations among DanishSLE patients: a prospective study on incidence, causes of admissionand risk factors in a population-based cohort. Lupus.2018;27(1):165-171. DOI: 10.1177/0961203317734919

  18. Levy O, Markov A, Drob Y, Maslakov I, Tishler M, Amit-Vazina M.All-cause hospitalizations in systemic lupus erythematosus from asingle medical center in Israel. Rheumatol Int. 2018;38(10):1841-1846. DOI: 10.1007/s00296-018-4147-5

  19. Liang H, Pan HF, Tao JH, Ye DQ. Causes and factors associatedwith frequent hospitalization in chinese patients with systemic lupuserythematosus: An ambispective cohort study. Med Sci Monit.

  20. 2019;25:8061-8068. DOI: 10.12659/MSM.91938120. Dhital R, Pandey RK, Poudel DR, Oladunjoye O, Paudel P, KarmacharyaP. All‑cause hospitalizations and mortality in systemiclupus erythematosus in the US: results from a national inpatientdatabase. Rheumatol Int. 2020;40:393–397. DOI: 10.1007/s00296-019-04484-5

  21. Aldarmaki R, Khogali HI, Dhanhani AMA. Hospitalization in patientswith systemic lupus erythematosus at Tawam Hospital,United Arab Emirates (UAE): Rates, causes, and factors associatedwith length of stay. Lupus. 2021;30(5):845–851. DOI:10.1177/0961203321990086

  22. Perrotta N, López Meiller MJ, Malah V, Dubinsky D. Causasde internación en pacientes con lupus eritematoso sistémicoen un hospital universitario de Buenos Aires. Reumatol Clin.2021;17(8):471–474. DOI: 10.1016/j.reuma.2020.04.013

  23. García-Cañas IE, Cuevas-Orta E, Herrera-Van Oostdam DA,Abud-Mendoza C, LUNPOS Group. Risk factors for hospitalizationin Mexican patients with systemic lupus erythematosus. Lupus.2024;33(8):892-898. DOI: 10.1177/09612033241249791

  24. Moreno-Torres V, Tarín C, Ruiz-Irastorza G, Castejón R, Gutiérrez-Rojas Á, Royuela A, et al. Trends in hospital admissions anddeath causes in patients with Systemic Lupus Erythematosus:Spanish National Registry. J. Clin. Med. 2021;10: 5749. DOI:10.3390/jcm10245749

  25. Lee YH, Song GG. Mortality in patients with systemic lupus erythematosus:A meta-analysis of overall and cause-specific effects.Lupus. 2024;33(9):929-937. DOI: 10.1177/09612033241257134.

  26. Lao C, White D, Rabindranath K, Van Dantzig P, Foxall D,Lawrenson R. Mortality and causes of death in systemic lupuserythematosus in New Zealand: a population-based study.Rheumatology. 2024, 63,1560–1567. DOI: 10.1093/rheumatology/kead427

  27. Assunção H, Rodrigues M, Prata AR, Luís M, da Silva JAP,Inês L. Predictors of hospitalization in patients with systemic lupuserythematosus: a 10-year cohort study. Clin Rheumatol.2022;41(10):2977-2986. DOI: 10.1007/s10067-022-06251-7

  28. Gladman DD, Urowitz MB. The SLICC/ACR damage index: progressreport and experience in the field. Lupus. 1999;8(8):632–637. DOI: 10.1191/ 09612 03996 80411 335




2020     |     www.medigraphic.com